Solara Active Pharma Sciences Current Share Price | Solara Active Pharma Sciences Stock Screener
SOLARA
Pharmaceuticals
Solara Active Pharma Sciences Current Stock Price Today
Live Share Price NSE
₹742.05
▲
0.35 (0.05%)
Live Share Price BSE
₹740.80
▲
0.10 (0.01%)
As of September 18, 2026, the live Solara Active Pharma Sciences share price (NSE: SOLARA) is ₹742.05 on NSE and ₹740.80 on BSE, up 0.05% from the previous close, with shares trading between ₹730.00 and ₹750.40 in today's trading session, and a 52-week range of ₹425.55–₹749.15.
Browse Solara Active Pharma Sciences annual reports to support your investment research.
Use the Solara Active Pharma Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Solara Active Pharma Sciences Market Cap
₹3,415.21 Cr.
SOLARA P/E Ratio (TTM)
-2203.09
Solara Active Pharma Sciences P/B Ratio
2.71
EPS (TTM)
₹-1.68
Dividend Yield
-
Debt to Equity
0.63
SOLARA 52 Week High
₹749.15
Solara Active Pharma Sciences 52 Week Low
₹425.55
Operating Margin
16.00%
Profit Margin
4.17%
SOLARA Revenue (TTM)
₹384.00
EBITDA
₹65.00
Net Income
₹16.00
Total Assets
₹2,333.00
Total Equity
₹1,256.00
Solara Active Pharma Sciences Current Share Price Chart
Track the current Solara Active Pharma Sciences share price and stock price with an interactive chart. Analyse SOLARA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Solara Active Pharma Sciences stock quote in one place.
Solara Active Pharma Sciences Company Profile - Fundamental Screener
Screen Solara Active Pharma Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SOLARA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE624Z01016
Solara Active Pharma Sciences Balance Sheet Screener
Screen SOLARA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 2,333 | 2,232 | 2,351 | 2,899 | 2,945 | 2,614 | 2,154 | 1,960 | 1,822 |
| Current Assets | 858 | 729 | 801 | 1,188 | 1,239 | 1,058 | 672 | 648 | 608 |
| Fixed Assets | 1,238 | 1,193 | 1,268 | 1,364 | 1,356 | 1,382 | 1,397 | 1,218 | 1,086 |
| Liabilities | |||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 183 | 191 | 172 | 296 | 354 | 232 | 333 | 344 | 315 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 1,256 | 1,097 | 937 | 1,502 | 1,527 | 1,593 | 1,090 | 960 | 769 |
| Share Capital | 45 | 40 | 36 | 36 | 36 | 36 | 27 | 26 | 25 |
| Reserves & Surplus | 1,208 | 1,054 | 898 | 1,464 | 1,489 | 1,553 | 963 | 826 | 739 |
Solara Active Pharma Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Solara Active Pharma Sciences income statement and profit fundamentals.
Analyze SOLARA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Solara Active Pharma Sciences share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 384 | 393 | 349 | 314 | 320 | 279 | 302 | 347 | 364 | 301 | 212 | 426 | 354 | 385 | 402 |
| Expenses | 320 | 330 | 318 | 279 | 262 | 228 | 243 | 286 | 322 | 412 | 436 | 393 | 333 | 332 | 350 |
| EBITDA | 65 | 63 | 31 | 35 | 58 | 51 | 59 | 62 | 43 | -111 | -224 | 34 | 21 | 53 | 52 |
| Operating Profit % | 16.00% | 15.00% | 9.00% | 11.00% | 18.00% | 17.00% | 19.00% | 18.00% | 12.00% | -38.00% | -106.00% | 8.00% | 5.00% | 13.00% | 11.00% |
| Depreciation | 27 | 26 | 26 | 25 | 24 | 24 | 25 | 25 | 25 | 25 | 26 | 26 | 26 | 27 | 28 |
| Interest | 22 | 28 | 23 | 21 | 24 | 29 | 27 | 28 | 31 | 31 | 25 | 24 | 25 | 22 | 24 |
| Profit Before Tax | 16 | 10 | -17 | -10 | 11 | -2 | 8 | 8 | -14 | -167 | -275 | -17 | -29 | 5 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 89 | 0 | 0 | -10 | 1 | 0 |
| Net Profit | 16 | 10 | -17 | -10 | 11 | -2 | 8 | 8 | -14 | -255 | -275 | -17 | -19 | 4 | 0 |
| EPS | 3.52 | 2.20 | -3.98 | -2.36 | 2.46 | -0.93 | 2.03 | 2.54 | -3.50 | -70.93 | -72.07 | -4.77 | -5.43 | 1.05 | 0.12 |
Solara Active Pharma Sciences Cash Flow Screener - Liquidity Fundamentals
Screen SOLARA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 153 | 213 | 109 | 156 | -242 | 156 | 242 | 166 | 49 |
| Investing Activities | -99 | -37 | -4 | -81 | -243 | -106 | -359 | -113 | -86 |
| Financing Activities | -54 | -181 | -106 | -113 | 334 | 93 | 97 | -23 | 68 |
| Net Cash Flow | 1 | -5 | 0 | -38 | -151 | 142 | -20 | 30 | 32 |
Solara Active Pharma Sciences Shareholding Pattern Screener
See Solara Active Pharma Sciences shareholding pattern with promoter, FII, and DII holdings.
Check Solara Active Pharma Sciences promoter holding and ownership changes for SOLARA on TickJournal.
| Item | 2026-Jun | 2026-May | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 41.93% | 42.00% | 42.00% | 42.00% | 42.01% | 42.01% | 37.94% | 37.23% |
| FII Holding | 11.52% | 11.33% | 11.59% | 11.98% | 13.58% | 14.25% | 14.63% | 14.67% |
| DII Holding | 3.74% | 3.78% | 3.75% | 3.64% | 2.69% | 2.62% | 2.61% | 3.19% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 25.84% | 25.15% | 25.03% | 24.63% | 24.01% | 23.47% | 23.07% | 21.93% |
| Other Holding | 16.97% | 17.74% | 17.63% | 17.74% | 17.70% | 17.63% | 21.74% | 22.98% |
| Shareholder Count | 70,490 | 70,037 | 70,400 | 71,920 | 72,479 | 74,334 | 75,791 | 83,148 |
Solara Active Pharma Sciences Share Dividend Screener - Share Yield Analysis
Check Solara Active Pharma Sciences dividend history with payout and yield data.
View Solara Active Pharma Sciences dividend details including ex-dates and amounts for SOLARA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹3.00 | 0.88% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹7.00 | 1.14% |
| 2020-March | ₹2.00 | 0.16% |
| 2019-March | ₹5.00 | 1.22% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Solara Active Pharma Sciences Stock Index Membership
See which indices include Solara Active Pharma Sciences stock.
Check SOLARA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Solara Active Pharma Sciences Market Events Screener - Corporate Actions
Get Solara Active Pharma Sciences corporate actions including splits, bonuses, and buybacks.
Check Solara Active Pharma Sciences stock events that may affect SOLARA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-18 | 2026-09-18 | Annual General Meeting | NA | 19.21% |
| 2026-07-23 | 2026-07-23 | Quarterly Result Announcement | NA | -7.25% |
| 2026-05-15 | 2026-05-15 | Quarterly Result Announcement | NA | -1.74% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 3.68% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | 4.92% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | 1.93% |
| 2025-07-25 | 2025-07-25 | Quarterly Result Announcement | NA | -5.12% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 19.48% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | 3.97% |
| 2024-10-21 | 2024-10-21 | Quarterly Result Announcement | NA | 8.11% |
| 2024-09-20 | 2024-09-20 | Annual General Meeting | NA | 6.04% |
| 2024-05-15 | 2024-05-15 | Rights | 1:3 | 8.26% |
| 2021-08-18 | 2021-08-20 | Dividend | ₹ 3.00 /share | 5.36% |
| 2017-03-25 | 2017-03-25 | Change Of Name | NA | - |
Solara Active Pharma Sciences Competitors Screener - Peer Comparison
Screen SOLARA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 440,278 | 36.48 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 244,178 | 84.64 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 184,478 | 87.77 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 110,585 | 24.32 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,140 | 32.86 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 104,025 | 97.64 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,570 | 30.44 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 95,513 | 25.98 | 34,145 | 5.56% | 3,503 | 53.00 |
| Lupin | 94,336 | 17.27 | 29,039 | 26.75% | 5,356 | 24.64 |
| Mankind Pharma | 94,184 | 45.49 | 14,636 | 14.85% | 1,938 | 37.66 |
Solara Active Pharma Sciences Company Announcements - News Screener
Screen SOLARA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-28 | Intimation In Connection With The Receipt Of Rectification Order | - |
| 2026-08-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-25 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-25 | Reg. 34 (1) Annual Report. | - |
| 2026-08-25 | Notice Of The Ninth Annual General Meeting | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-19 | Conversion Of Partly Paid-Up Rights Equity Shares Into Fully Paid-Up Equity Shares In Relation To The Rights Issue By The Company Upon Receipt Of The Call Monies As Applicable | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-08-07 | Update With Respect To Our Intimation Dated July 23 2026 Regarding Appointment Of CIO And SMP Of The Company. | - |
| 2026-07-29 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-24 | Submission Of Machine Readable Copy Of Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-07-23 | Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30 2026. | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-07-23 | Intimation About Appointment Of Chief Information Officer (CIO) | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-23 | Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-07-23 | Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2026. | - |